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Abstract: Sufu (Suppressor of Fused), a two-domain protein, plays a critical role in regulating
Hedgehog signaling and is conserved from flies to humans. A few bacterial Sufu-like proteins have
previously been identified based on sequence similarity to the N-terminal domain of eukaryotic
Sufu proteins, but none have been structurally or biochemically characterized and their function in
bacteria is unknown. We have determined the crystal structure of a more distantly related Sufu-like
homolog, NGO1391 from Neisseria gonorrhoeae, at 1.4 A˚ resolution, which provides the first
biophysical characterization of a bacterial Sufu-like protein. The structure revealed a striking
similarity to the N-terminal domain of human Sufu (r.m.s.d. of 2.6 A˚ over 93% of the NGO1391
protein), despite an extremely low sequence identity of ~15%. Subsequent sequence analysis
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revealed that NGO1391 defines a new subset of smaller, Sufu-like proteins that are present in ~200
bacterial species and has resulted in expansion of the SUFU (PF05076) family in Pfam.
Keywords: Neisseria gonorrhoeae; NGO1391; UniProt Q5F6Z8; Pfam PF05076; suppressor of fused;
sufu-like; structural genomics
Introduction
The Hedgehog (Hh) and Wingless (Wnt) signaling
pathways are critical for animal development.1–4
They are important in embryonic growth in verte-
brates and stem cell differentiation. Disruption of
these pathways can lead to disruption of stem cell
function and cancer, for example.5,6 Recent studies
have addressed how these pathways may have
evolved.7–9 The human Sufu (Suppressor of Fused)
protein is a key transcriptional regulator in the Hh
pathway. Until recently, 20 eukaryotic, two-domain
proteins of 500 residues [N-terminal domain: Pfam
SUFU family (PF05076) and C-terminal domain:
Pfam SUFU_C family (PF12470)] and 13 bacterial
Sufu-like single-domain proteins of unknown func-
tion (250 residues, with 25–40% sequence iden-
tity to the N-terminal Sufu domain of eukaryotic
proteins) were classified in Pfam (version 23.0).10
The Sufu_C domain interacts with the N-terminal
domain of Gli transcription factors, whereas the
Sufu domain is believed to interact with the C-termi-
nal tail of Gli.11,12 Apart from general classification
of these bacterial proteins as Sufu-like, none had
been investigated experimentally and their roles
were consequently unclear, since bacteria do not use
Hedgehog signaling.
As part of our efforts to characterize novel pro-
tein sequence space, we identified a set of proteins in
Neisseria species that are distantly related to mem-
bers of PF05076. This similarity was only detectable
using profile–profile sequence comparison methods.13
NGO1391 (UniProt id Q5F6Z8) from Neisseria gonor-
rhea FA1090 was selected as a representative of this
set for structure determination, using the semiauto-
mated, high-throughput pipeline of the Joint Center
for Structural Genomics (JCSG; http://www.jcsg.org)
as part of the National Institute of General Medical
Sciences’ Protein Structure Initiative.
Results and Discussion
Overall structure
NGO1391 from Neisseria gonorrhoeae FA 1090 was
cloned, expressed, purified, and crystallized accord-
ing to JCSG protocols as described in Materials and
Methods. The crystal structure (Fig. 1) was deter-
mined by single-wavelength anomalous diffraction
(SAD) phasing to a resolution of 1.40 A˚. Data collec-
tion, model, and refinement statistics are summar-
ized in Table I.14 The final model contains one mono-
mer consisting of Gly0 (from the purification tag)
and residues 1–181 of NGO1391 (the full-length pro-
tein is 182 residues), 265 waters, 4 sulfates, and 1
glycerol molecule in the asymmetric unit (ASU).
Residue 182 was disordered and was not modeled. A
monomer is the likely oligomeric form in solution as
judged from crystal lattice packing and assembly
analysis using PISA, and the monomeric form is
supported by analytical size-exclusion chromatogra-
phy. The Matthews’ coefficient (VM)
15 is 2.5 A˚3/Da,
with an estimated solvent content of 50%. The Ram-
achandran plot produced by Molprobity16 shows that
97.8% of the amino acids are in the favored regions
with one outlier, Asp132, which is in a region of
good density, but with alternate main-chain and
side-chain conformations.
NGO1391 is a compact molecule with approxi-
mate dimensions of 50 A˚  40 A˚  30 A˚ and has a
tapered appearance due to a bulkier N-terminal
region. It consists of a central, slightly S-shaped, anti-
parallel b-sheet (b1–b7) flanked by a- and 310-helices
(H1–H8) (Fig. 1). Some of the loops are long and
extend out from the protein core. The C-terminus con-
sists of a long tail with no secondary structure (resi-
dues 165–181). A glycerol molecule from the cryopro-
tectant binds in a relatively hydrophobic cleft formed
by Ser119, Tyr122, Trp138, Leu140, Glu159, Phe162,
Asp163, Ile167, and Tyr169 near the C-terminus.
Most of these residues are conserved in the newly
identified Sufu-like proteins (see Sequence Analysis)
and three are also conserved in human Sufu (Ser119,
Leu140 and Ile167 correspond to human Sufu
Thr180, Val201, and Ile228, respectively).
Comparison to human Sufu
A search for other proteins of similar structure using
sequence and structure-based methods was carried
out using FFAS,13 DALI,17 FATCAT,18 and SSM.19
In all cases, the only significant hit (for example, the
e-value of the top FATCAT hit is 3.95e-10 and the
next hit is 4.35e-03; the top DALI hit has a Z-score
of 16.7 and the next hit has 5.2, the top FFAS hit
has a score of 49.4 and the next hit is 5.7) was to
the N-terminal domain (NTD, 236 out of 484 resi-
dues) of the human Sufu protein (PDB accession
code 1m1l,12 UniProt Q9UMX1). NGO1391 can be
superimposed onto the NTD of Sufu with an r.m.s.d.
of 2.6 A˚ over 170 Ca atoms (93% of the NGO1391
protein) with structure-based (DALI) and sequence-
based (FFAS) sequence identities of 15% (Fig. 2). The
notable structural differences between NGO1391 and
the NTD of Sufu include: short helices H2 and H3 in
NGO1391 correspond to long loops in Sufu; longer
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loops in Sufu occur between strands b2 and b3, b3
and H3, and b4 and H4; and additional helices are
present near the C-terminus.
Human full-length Sufu was found to be a
monomer in solution (n.b. the NTD of Sufu forms a
tetramer in the crystal structure and only the NTD
3D structure of human Sufu is available). In its
inactive signaling state, the NTD of Sufu interacts
with the C-terminal region of Gli transcription fac-
tors and prevents their transport into the nucleus.
In the active form, which is phosphorylation depend-
ent, Sufu forms a complex with Fused, thereby
releasing Gli. Asp159 of Sufu was found to be impor-
tant in the interaction with Gli.12 This residue corre-
sponds to Lys99 in NGO1391 (Fig. 3), which in itself
is not highly conserved across the bacterial Sufu-like
Figure 1. Crystal structure of NGO1391 from Neisseria gonorrhoea FA1090. (a) Stereo ribbon diagram of the NGO1391
monomer color-coded from N-terminus (yellow) to C-terminus (magenta). Helices H1–H8 (helix H5 is a 310 helix) and b-strands
b1-b7 are indicated. (b) Diagram showing the secondary structural elements of NGO1391 superimposed on its primary
sequence. The a-helices, 310 helix, and b-strands are indicated.
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proteins. Seven residues contribute to a more negatively
charged region on one side of Sufu: Glu106, Asp111,
Glu152, Asp159, Glu181, Glu221, and Asp262 (Fig. 4).
These residues are not conserved across bacterial Sufu-
like proteins. Both sides of NGO1391 appear to have a
similar number of negatively charged residues (Fig. 4).
Some other residues are more strongly conserved
between the eukaryotic and bacterial forms of the pro-
tein with several on the protein surface (NGO1391
Thr24, Glu49, Trp51, Tyr53, Pro106, Ser111, and
His115) that could be functionally important.
Sequence analysis and genomic context
At the time of the NGO1391 structure determina-
tion, Pfam (version 23.0) SUFU family (PF05076)
contained 33 proteins from 27 species, 20 of which
were eukaryotic including the N-terminal domain of
human Sufu and 13 were bacterial. The eukaryotic
Sufu proteins (primarily from chordates and insects)
all contained 500 residues, and consisted of two
domains of approximately equal size (Sufu and
Sufu_C). The bacterial proteins, on the other hand,
were uncharacterized proteins of only around 250
residues.
A search against the UniProt database using
PSI-BLAST revealed that NGO1391 (Q5F6Z8) had
several sequence homologs of 92% sequence identity
in other Neisseria species: N. gonorrhoeae 1291
(C1HYY6), N. gonorrhoeae NCCP11945 (B4RNC6), N.
flavescens NRL30031/H210 (C0EME3), N. meningiti-
dis serogroup C/serotype 2a (A1KSR8), N. cinerea
ATCC14685 (C0DN13), and N. lactamica ATCC23970
(C0F5L2). The next nearest hits were to proteins with
33–39% sequence identity (B5HWZ3 from Streptomy-
ces sviceus ATCC 29083, C2A7G8 from Thermomono-
spora curvata DSM 43183, C1YUI8 from Nocardiopsis
dassonvillei subsp. dassonvillei DSM 43111 and
A6A6Q5 from Vibrio cholerae MZO-2). However, none
of these proteins (Fig. 3) were included in PF05076.
Three rounds of iterative PSI-BLAST, including
sequence similarities down to a threshold of 0.1,
identified 300 additional bacterial proteins, in
addition to the 33 vertebrate and bacterial Sufu pro-
teins already present in PF05076. Pairwise compari-
sons revealed that the bacterial proteins already
included in PF05076 had sequence identities of 25–
40% to the eukaryotic Sufu proteins, but less than
16% identity to the additional Sufu-like proteins iden-
tified here. A multiple sequence alignment of a repre-
sentative set of these new Sufu-like proteins identified
residues that are invariant or similar in these proteins
(Fig. 3) and their distribution in the structure (Fig. 5).
Table I. Summary of Crystal Parameters, Data Collection, and Refinement Statistics for PDB 3k5j
Space group P3221
Unit cell parameters a ¼ 50.72 A˚, b ¼ 50.72 A˚, c ¼ 143.60 A˚
Data collection k1 SAD-Se
Wavelength (A˚) 0.9789
Resolution range (A˚) 27.7–1.40
Number of observations 365,215
Number of unique reflections 43,173
Completeness (%) 99.7 (98.6)a
Mean I/r (I) 17.2 (1.8)a
Rsym on I (%) 6.0 (76.1)
a
Highest resolution shell (A˚) 1.45–1.40
Model and refinement statistics
Resolution range (A˚) 27.7–1.40 Data set used in refinement k1 SAD-Se
Number of reflections (total) 43,107b Cutoff criteria |F|>0
Number of reflections (test) 2169 Rcryst 0.134
Completeness (% total) 99.8 Rfree 0.163
Stereochemical parameters
Restraints (RMSD observed)
Bond angle () 1.60
Bond length (A˚) 0.015
Average protein isotropic B-value (A˚2) 20.3c
ESU based on Rfree (A˚) 0.05
No. of protein residues/atoms 182/1593
No. of water/sulfate/glycerol molecules 265/4/1
ESU ¼ Estimated overall coordinate error.14
Rsym ¼ R|IihIii|/R|Ii|, where Ii is the scaled intensity of the ith measurement and hIii is the mean intensity for that
reflection.
Rcryst ¼ R||Fobs||Fcalc||/R|Fobs|, where Fcalc and Fobs are the calculated and observed structure factor amplitudes,
respectively.
Rfree ¼ as for Rcryst, but for 5.0% of the total reflections chosen at random and omitted from refinement.
a Highest resolution shell.
b Typically, the number of unique reflections used in refinement is slightly less that the total number that were integrated and
scaled. Reflections are excluded due to negative intensities and rounding errors in the resolution limits and cell parameters.
c This value represents the total B.
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Based on this analysis, Pfam PF05076 was independ-
ently revised to include these proteins using the
HMMER3 software (http://hmmer.janelia.org). Thus,
PF05076 in the current release of Pfam (v. 24.0, Octo-
ber 2009) now contains 341 proteins from 31 eukaryo-
tic and 220 bacterial species. Inspection of the residue
conservation scores in the multiple sequence align-
ment for this revised protein family on the Pfam web-
site (http://pfam.sanger.ac.uk/family/PF05076), reveals
that the only residues that that are conserved across
the entire protein family (341 proteins) are Val134,
Phe136, Leu139, Ile142, Glu146, and Leu158 in
NGO1391. Of these residues, only Val134 is surface
exposed whereas the rest are in the protein core.
The genomic neighbors of NGO1391 are putative
MafB-like (NGO1392) and MafA2 (NGO1393) proteins
that are predicted to be functional partners of
NGO1391 with high scores of 0.87 and 0.86, respec-
tively.22 The Maf proteins are believed to have adhe-
sion capabilities.23,24 Interestingly, this predicted
association is similar to that of the b-catenin in the
Wnt signaling pathway, where b-catenin can form a
complex with the cadherin cell-adhesion molecules.
b-catenin also functions as a transcriptional regula-
tor. However, no sequence or structural similarity is
found between NGO1391 and b-catenin and this
genomic context does not appear to be conserved
across other members of this Pfam.
The crystal structure and sequence analysis pre-
sented here provides the first molecular characteri-
zation of a bacterial Sufu-like protein that may be a
prokaryotic homolog of modern Sufu proteins
involved in embryonic development in vertebrates.
This study has also led to identification of a large
number of other bacterial Sufu-like proteins. Mecha-
nistic and mutagenesis experiments can help to elu-
cidate which residues are important for molecular
function and substrate specificity and aid in
understanding the function of NGO1391 and
related proteins. Additional information about
the proteins described in this study is available
from TOPSAN25,26 at http://www.topsan.org/
explore?PDBid¼3k5j.
Materials and Methods
Protein expression, purification, and
crystallization
Clones were generated using the Polymerase Incom-
plete Primer Extension (PIPE) cloning method.27
The gene encoding NGO1391 (GenBank: YP_208451,
gi|59801739, UniProt: Q5F6Z8) was amplified by poly-
merase chain reaction (PCR) from Neisseria gonor-
rhoeae genomic DNA using PfuTurbo DNA poly-
merase (Stratagene) and I-PIPE (Insert) primers
(forward primer: 50-ctgtacttccagggc ATGGACTATAA
CCAAACTGTTTTATCTC30, reverse primer: 50-aat
taagtcgcgtta TCCTGCCTGCCAGACAGTACTCGC
ACG-30, target sequence in upper case) that included
sequences for the predicted 50 and 30 ends. The
expression vector, pSpeedET, which encodes an
amino-terminal tobacco etch virus (TEV) protease-
cleavable expression and purification tag (MGSDK
IHHHHHHENLYFQ/G), was PCR amplified with
V-PIPE (Vector) primers (forward primer: 50-taacgc
gacttaattaactcgtttaaacggtctccagc-30, reverse primer:
50-gccctggaagtacaggttttcgtgatgatgatgatgatg-30). V-PIPE
and I-PIPE PCR products were mixed to anneal the
amplified DNA fragments together. Escherichia coli
GeneHogs (Invitrogen) competent cells were trans-
formed with the I-PIPE/V-PIPE mixture and dis-
pensed on selective LB-agar plates. The cloning junc-
tions were confirmed by DNA sequencing. Expression
was performed in a selenomethionine-containing me-
dium at 37C. Selenomethionine was incorporated via
inhibition of methionine biosynthesis, which does
not require a methionine-auxotrophic strain.28 At
the end of fermentation, lysozyme was added to the
culture to a final concentration of 250 lg/mL, and
the cells were harvested and frozen. After one
freeze/thaw cycle the cells were sonicated in lysis
buffer [50 mM HEPES pH 8.0, 50 mM NaCl, 10 mM
Figure 2. Structural comparison of NGO1391 and human
Sufu protein. The structures of NGO1391 and the N-terminal
domain (NTD) of human Sufu protein (gray) are highly similar
and superimpose with an r.m.s.d. of 2.6 A˚ over 170 Ca atoms.
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imidazole, 1 mM Tris(2-carboxyethyl)phosphine-HCl
(TCEP)] and the lysate was clarified by centrifuga-
tion at 32,500  g for 30 minutes. The soluble frac-
tion was passed over nickel-chelating resin (GE
Healthcare) pre-equilibrated with lysis buffer, the
resin was washed with wash buffer [50 mM HEPES
pH 8.0, 300 mM NaCl, 40 mM imidazole, 10% (v/v)
glycerol, 1 mM TCEP], and the protein was eluted
with elution buffer [20 mM HEPES pH 8.0, 300 mM
imidazole, 10% (v/v) glycerol, 1 mM TCEP]. The elu-
ate was buffer exchanged with TEV buffer [20 mM
HEPES pH 8.0, 200 mM NaCl, 40 mM imidazole, 1
mM TCEP] using a PD-10 column (GE Healthcare),
and incubated with 1mg of TEV protease per 15 mg
of eluted protein. The protease-treated eluate was
passed over nickel-chelating resin (GE Healthcare)
pre-equilibrated with HEPES crystallization buffer
[20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM imid-
azole, 1 mM TCEP] and the resin was washed with
the same buffer. The flow-through and wash frac-
tions were combined and concentrated for crystalli-
zation trials to 13 mg/mL by centrifugal ultrafiltra-
tion (Millipore). NGO1391 was crystallized by
mixing 200 nL protein solution with 200 nL crystal-
lization solution in a sitting drop format over a 50
lL reservoir volume using the nanodroplet vapor
Figure 3. Multiple sequence alignment of Sufu-like proteins. The Neisseria proteins with UniProt codes Q5F6Z8 (NGO1391)
from N. gonorrhoeae FA1090 , C1HYY6 from N. gonorrhoeae 1291, B4RNC6 from N. gonorrhoeae NCCP11945, C0EME3
from N. flavescens NRL30031/H210, A1KSR8 from N. meningitidis serogroup C/serotype 2a, C0DN13 from N. cinerea
ATCC14685 and C0F5L2 from N. lactamica ATCC23970 share 92% sequence identity. More distant homologs with
33–39% sequence identity are B5HWZ3 from Streptomyces sviceus ATCC 29083, C2A7G8 from Thermomonospora curvata
DSM 43183, C1YUI8 from Nocardiopsis dassonvillei subsp. dassonvillei DSM 43111, and A6A6Q5 from Vibrio cholerae
MZO-2. The alignment was generated using the CLUSTALW web-server.20
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diffusion method29 with standard JCSG crystalliza-
tion protocols.30 The crystallization reagent consisted
of 1.6M ammonium sulfate, and 0.1M MES pH 6.0.
Glycerol was diluted using the reservoir solution
and then added 1:1 to the drop to a final concentra-
tion 20% (v/v) as a cryoprotectant prior to harvest-
ing. A cubic-shaped crystal of approximate size 100
lm  100 lm  100 lm was harvested after 15 days
at 277 K for data collection. Initial screening for dif-
fraction was carried out using the Stanford Auto-
mated Mounting system (SAM)31 at the Stanford Syn-
chrotron Radiation Lightsource (SSRL, SLAC
National Accelerator Laboratory, Menlo Park, CA).
The diffraction data were indexed in trigonal space
Figure 4. Electrostatic surface potential representations of human Sufu and NGO1391. (a) Surface for the NTD of human
Sufu shows a greater accumulation of negatively charged residues on one side (left panel) of the protein due to surface
residues Glu106, Asp111, Glu152, Asp159, Glu181, Glu221, and Asp262. (b) Surface for the NGO1391 indicates that charged
residues are equally distributed on both sides of the protein. The color scale is in units of kT/e from 9 to þ9. The figure in
the right panel represents a 180 rotation around the vertical axis compared to the left panel.
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group P3221. Protein concentrations were determined
using the Coomassie Plus assay (Pierce). To determine
its oligomeric state in solution, NGO1391 was ana-
lyzed using a 1  30 cm2 Superdex 200 size-exclusion
column (GE Healthcare). The mobile phase consisted
of 20 mM Tris pH 8.0, 150 mM NaCl, and 0.02% (w/
v) sodium azide. The molecular weight was calculated
using ASTRA 5.1.5 software (Wyatt Technology).
Figure 5. Sequence conservation plot of NGO1391. The Sufu-like proteins from Figure 3 have been used for the calculation
of conservation scores21 (a) A stereo stick representation in which the most conserved residues are represented in dark pink,
the light pink residues are less conserved and residues in cyan are least conserved. (b) and (c) Two views of some of the
most conserved surface exposed residues in the same color scheme. The molecular orientations in the top and bottom
panels are different to facilitate visualization using PyMOL.
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Data collection, structure solution, and
refinement
SAD data were collected at 100 K using a MarMo-
saic 325 CCD detector (Rayonix) at the SSRL on
beamline 11–1 at the selenium peak (k1) wavelength
using the BLU-ICE32 data collection environment.
The SAD data were integrated and reduced using
XDS33 and XSCALE, respectively. All other pro-
grams for data manipulation were from the CCP4
suite.34 The heavy atom substructure and phasing
calculations were performed using SHELXD35 and
autoSHARP36, respectively, and ARP/wARP37 was
used for automatic model building to 1.40 A˚ resolu-
tion. Model completion and crystallographic refine-
ment were performed using COOT38 and
REFMAC5,39 respectively. The refinement protocol
included the experimental phase restraints in the
form of Hendrickson–Lattman coefficients from
autoSHARP. Data and refinement statistics are sum-
marized in Table I.
Validation and deposition
The quality of the crystal structure was analyzed
using the JCSG Quality Control server (http://
smb.slac.stanford.edu/jcsg/QC). This server auto-
matically processes the coordinates and data
through a variety of validation tools including Auto-
DepInputTool,40 MolProbity,16 WHATIF 5.0;41 agree-
ment between the atomic model and the data using
SFcheck 4.042 and RESOLVE,43 the protein sequence
using CLUSTALW,44 atomic occupancies using
MOLEMAN2,45 consistency of NCS pairs and evalu-
ates difference in Rcryst/Rfree, expected Rfree/Rcryst
and maximum/minimum B-factors by parsing the
refinement log-file and PDB header. Protein quater-
nary structure analysis was performed using the
PISA server,46 Figure 1(B) was adapted from an
analysis using PDBsum,47 and all others were pre-
pared with PyMOL.48 Figure 3 was prepared using
the PDB2PQR49 server and the APBS49,50 module in
PyMOL. Atomic coordinates and experimental struc-
ture factors for NGO1391 have been deposited in the
PDB under the accession code 3k5j.
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